These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 12850638)

  • 21. Heat-related toxicity with the fentanyl transdermal patch.
    Newshan G
    J Pain Symptom Manage; 1998 Nov; 16(5):277-8. PubMed ID: 9846020
    [No Abstract]   [Full Text] [Related]  

  • 22. The use of transdermal fentanyl in pediatric oncology palliative care.
    Noyes M; Irving H
    Am J Hosp Palliat Care; 2001; 18(6):411-6. PubMed ID: 11712724
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Patching together transdermal pain control options.
    D'Arcy Y
    Nursing; 2005 Sep; 35(9):17. PubMed ID: 16148763
    [No Abstract]   [Full Text] [Related]  

  • 24. The effectiveness of transdermal fentanyl in palliative care.
    Evans R
    Nurs Times; 2003 Oct 14-20; 99(41):24-5. PubMed ID: 14603653
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of local administration of transdermal fentanyl on peripheral opioid analgesia.
    Worrich S; Schuler G; Janicki PK
    Pain Med; 2007; 8(1):41-7. PubMed ID: 17244103
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pain recurrence on the third day after application of a transdermal fentanyl patch.
    Konishi H; Ishihara C; Chiba M; Endo Y; Yamaji A
    Pharm World Sci; 2005 Aug; 27(4):353. PubMed ID: 16228637
    [No Abstract]   [Full Text] [Related]  

  • 27. Results of the clinical trial of transdermal therapeutic system-fentanyl in strong opioid pre-treated adult patients with cancer-related pain.
    Besova N; Gorbounova V; Saltanov A; Zarouk V
    Gan To Kagaku Ryoho; 2000 May; 27 Suppl 2():378-84. PubMed ID: 10895182
    [No Abstract]   [Full Text] [Related]  

  • 28. Failure of pain control using transdermal fentanyl during rifampicin treatment.
    Morii H; Chiba M; Konishi H; Endo Y; Yamaji A
    J Pain Symptom Manage; 2007 Jan; 33(1):5-6. PubMed ID: 17196900
    [No Abstract]   [Full Text] [Related]  

  • 29. Physicians' knowledge of transdermal fentanyl.
    Lidstone V; Owen R
    Palliat Med; 2005 Oct; 19(7):566-7; author reply 567-8. PubMed ID: 16295292
    [No Abstract]   [Full Text] [Related]  

  • 30. Physicians' knowledge of transdermal fentanyl.
    McGregor A
    Palliat Med; 2005 Oct; 19(7):566; author reply 567-8. PubMed ID: 16295291
    [No Abstract]   [Full Text] [Related]  

  • 31. In brief: heat and transdermal fentanyl.
    Med Lett Drugs Ther; 2009 Aug; 51(1318):64. PubMed ID: 19661852
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Perioperative management of patients with cancer-pain receiving fentanyl patch].
    Takahashi R; Waseda Y; Nitta S
    Masui; 2008 Jul; 57(7):886-8. PubMed ID: 18649645
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Drug-use evaluation of transdermal fentanyl.
    Shamilian A
    Am J Health Syst Pharm; 1995 Nov; 52(22):2597-8. PubMed ID: 8590247
    [No Abstract]   [Full Text] [Related]  

  • 34. Factors predicting requirement of high-dose transdermal fentanyl in opioid switching from oral morphine or oxycodone in patients with cancer pain.
    Kanbayashi Y; Hosokawa T; Okamoto K; Fujimoto S; Konishi H; Otsuji E; Yoshikawa T; Takagi T; Miki T; Taniwaki M
    Clin J Pain; 2011 Oct; 27(8):664-7. PubMed ID: 21471811
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Three-cycle fentanyl patch system significantly improves pain control in gynecologic cancer.
    Kanamori C; Kanamori T; Hayashi M; Yorioka H; Kanzaki H
    J Obstet Gynaecol Res; 2006 Dec; 32(6):605-9. PubMed ID: 17100824
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Is the use of transdermal fentanyl inappropriate according to the WHO guidelines and the EAPC recommendations? A study of cancer patients in Italy.
    Ripamonti C; Fagnoni E; Campa T; Brunelli C; De Conno F
    Support Care Cancer; 2006 May; 14(5):400-7. PubMed ID: 16485087
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transdermal fentanyl: caution in the use of high doses.
    Botterman J; De Meester C; Eeckhaut K
    Palliat Med; 2004 Oct; 18(7):663. PubMed ID: 15540677
    [No Abstract]   [Full Text] [Related]  

  • 38. [Fentanyl patch in the treatment of severe chronic pain].
    Nolte T
    MMW Fortschr Med; 2009 Oct; 151(40):45. PubMed ID: 19927919
    [No Abstract]   [Full Text] [Related]  

  • 39. A safe and effective method for converting cancer patients from intravenous to transdermal fentanyl.
    Kornick CA; Santiago-Palma J; Khojainova N; Primavera LH; Payne R; Manfredi PL
    Cancer; 2001 Dec; 92(12):3056-61. PubMed ID: 11753984
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Staged pain therapy plan. Opioid patch for chronic pain].
    MMW Fortschr Med; 2002 May; Suppl 2():71. PubMed ID: 12070857
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.